| |
| |
|
| Insider
Information: |
Wiggans Thomas G |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
172,287 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$814,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
172,287 |
|
|
| Total
Value |
$814,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -42.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2007-08-29 |
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2012-07-02 |
122,287 |
2008-12-31 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
2022-10-14 |
0 |
2021-06-17 |
0 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Chief Executive Office... |
2023-08-31 |
0 |
2022-12-01 |
0 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-11-28 |
50,000 |
2023-11-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-11-28 |
4 |
B |
$0.65 |
$6,486 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-11-21 |
4 |
B |
$0.64 |
$6,383 |
D/D |
10,000 |
40,000 |
2.39 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-11-20 |
4 |
B |
$0.63 |
$6,309 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-11-17 |
4 |
B |
$0.60 |
$5,966 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
Director |
– • – |
2023-11-16 |
4 |
B |
$0.60 |
$5,965 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Executive Officer |
• • – |
2023-08-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,000) |
0 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Executive Officer |
• • – |
2022-12-05 |
4 |
B |
$1.09 |
$13,625 |
D/D |
12,500 |
50,000 |
2.81 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Executive Officer |
• • – |
2022-12-02 |
4 |
B |
$1.07 |
$13,375 |
D/D |
12,500 |
37,500 |
2.81 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Executive Officer |
• • – |
2022-12-01 |
4 |
B |
$1.04 |
$26,000 |
D/D |
25,000 |
25,000 |
2.81 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,250) |
0 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
2,750 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$262,500 |
D/D |
(2,100) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$751,875 |
D/D |
(6,015) |
2,100 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
850 |
8,115 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-06 |
4 |
AS |
$91.01 |
$409,545 |
D/D |
(4,500) |
8,965 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-06 |
4 |
OE |
$25.30 |
$118,510 |
D/D |
4,500 |
13,465 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-05 |
4 |
AS |
$86.00 |
$318,200 |
D/D |
(3,700) |
8,965 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-05 |
4 |
OE |
$25.30 |
$63,250 |
D/D |
2,500 |
12,665 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
10,165 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-08 |
4 |
AS |
$85.00 |
$170,000 |
D/D |
(2,000) |
8,065 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-08 |
4 |
OE |
$27.63 |
$55,260 |
D/D |
2,000 |
10,065 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-05 |
4 |
AS |
$77.20 |
$193,000 |
D/D |
(2,500) |
8,065 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-05 |
4 |
OE |
$25.30 |
$63,250 |
D/D |
2,500 |
10,565 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-02-05 |
4 |
AS |
$77.29 |
$193,225 |
D/D |
(2,500) |
8,065 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-02-05 |
4 |
OE |
$25.30 |
$63,250 |
D/D |
2,500 |
10,565 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
